After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Bicycle Therapeutics Plc ADR is $635.35M. A total of 0.7 million shares were traded on the day, compared to an average of 319.75K shares.
In the most recent transaction, Thompson Travis Alvin sold 2,686 shares of BCYC for 15.00 per share on Jan 06 ’25. After the transaction, the CHIEF ACCOUNTING OFFICER now owns 32,146 company shares. In a previous transaction on Jan 02 ’25, Thompson Travis Alvin sold 1,750 shares at 14.09 per share. BCYC shares that CHIEF ACCOUNTING OFFICER owns now total 34,991.
Among the insiders who sold shares, Thompson Travis Alvin disposed of 159 shares on Jan 03 ’25 at a per-share price of $14.75. This resulted in the CHIEF ACCOUNTING OFFICER holding 34,832 shares of BCYC after the transaction. In another insider transaction, Young Alethia sold 1,395 shares at $14.09 per share on Jan 02 ’25. Company shares held by the Chief Financial Officer now total 45,605.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, BCYC has a high of $28.67 and a low of $9.00.
As of this writing, BCYC has an earnings estimate of -$0.81 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.69 per share and a lower estimate of -$0.9.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BCYC’s latest balance sheet shows that the firm has $438.68M in Cash & Short Term Investments as of fiscal 2021. There were $44.34M in debt and $36.24M in liabilities at the time. Its Book Value Per Share was $11.48, while its Total Shareholder’s Equity was $346.25M.
Analysts Opinion
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BCYC is Buy with a score of 4.38.
